Shannon N. Westin, MD, MPH

home / authors / shannon-n-westin-md-mph

Articles

Results of the ENPAC Trial Shows Promise in Recurrent Endometroid Cancer

Results of the ENPAC Trial Shows Promise in Recurrent Endometroid Cancer

Shannon N. Westin, MD, MPH
November 1st 2022

Shannon N. Westin, MD, MPH, discusses the promising results of the ENPAC trial that showed the effectiveness of adding enzalutamide to standard of care chemotherapy for patients with recurrent endometriod cancer.

DUO-E Trial Focuses on Treating High-Risk Endometrial Cancer

DUO-E Trial Focuses on Treating High-Risk Endometrial Cancer

Shannon N. Westin, MD, MPH
April 21st 2022

Shannon N. Westin, MD, MPH, FACOG, discusses the endometrial cancer patient population enrolled in the phase 3 DUO-E trial.

Immunotherapy Advances the Treatment Landscape of Endometrial Cancers

Immunotherapy Advances the Treatment Landscape of Endometrial Cancers

Shannon N. Westin, MD, MPH
May 7th 2020

Shannon N. Westin, MD, MPH, FACOG, discusses the evolving role of immunotherapy as treatment of patients with endometrial cancer.

Overcoming Resistance to PARP Inhibitors in Ovarian Cancer

Overcoming Resistance to PARP Inhibitors in Ovarian Cancer

Shannon N. Westin, MD, MPH
October 26th 2018

Shannon N. Westin, MD, MPH, discusses resistance seen with PARP inhibitors in ovarian cancer and how this resistance can be overcome.

Latest Updated Articles

FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
FDA Lifts Clinical Holds Placed on 3 CAR T-cell Therapy Trials
Published: November 4th 2024 | Updated: November 5th 2024
FDA Lifts Clinical Holds Placed on 3 CAR T-cell Therapy Trials
Intro and Overview of Bispecifics in Non-Hodgkin Lymphoma (NHL)
Published: September 30th 2024 | Updated: November 5th 2024
Intro and Overview of Bispecifics in Non-Hodgkin Lymphoma (NHL)
The Targeted Pulse: Uncover the Latest From WCLC and Experts Insights Into Latest Advances Across Cancer Types
Published: November 3rd 2024 | Updated: November 5th 2024
The Targeted Pulse: Uncover the Latest From WCLC and Experts Insights Into Latest Advances Across Cancer Types
The Present and Future of Endocrine Therapy in Breast Cancer
Published: October 24th 2024 | Updated: November 5th 2024
The Present and Future of Endocrine Therapy in Breast Cancer
Advances in Treating HER2+ Breast Cancer With Brain Metastases
Published: November 2nd 2024 | Updated: November 5th 2024
Advances in Treating HER2+ Breast Cancer With Brain Metastases